Systemic lupus erythematosus patients can develop recurrent angioedema through complement-mediated mechanisms despite having normal C1 esterase inhibitor levels and function, according to a case report published in the American Journal of Case Reports. The study details the medical course of a woman in her early 20s with lupus nephritis who experienced dangerous airway swelling driven by abnormal immune protein activity rather than traditional acquired angioedema pathways.
Understanding Complement Activation in Lupus-Related Swelling
Angioedema typically causes sudden, severe swelling in the face, limbs, and digestive tract, with throat involvement posing life-threatening risks by obstructing the airway, as outlined in the case study titled “From Sight to Stridor: Recurrent Angioedema in Systemic Lupus Erythematosus Associated With Complement Activation.” While acquired angioedema is commonly tied to a deficiency in the C1 esterase inhibitor (C1-INH) protein—which regulates the complement system and prevents excess bradykinin production—emerging clinical data highlights a different pathway. Researchers noted that patients with active systemic lupus erythematosus (SLE) can experience recurrent swelling even when their C1-INH levels and function remain completely normal.
Did you know? While C1-INH deficiencies typically drive acquired angioedema through uncontrolled bradykinin signaling, lupus-related swelling can stem directly from abnormal immune protein cascades without altering C1-INH metrics.
Clinical Presentation and Airway Involvement in the Patient Case
The patient, who was already undergoing treatment for lupus nephritis—a severe kidney inflammation complication of SLE—sought care for urinary symptoms, worsening renal function, and gastrointestinal distress including nausea, vomiting, and diarrhea. While waiting at an urgent care clinic, she developed sudden, substantial swelling around her left eye, which doctors initially treated with antibiotics for presumed urinary and eye infections after a CT scan revealed fluid accumulation around the intestines and eye tissues.
The following day after hospital admission, her condition escalated as she developed retching, excessive saliva, a sore throat, and hoarseness. A bedside laryngoscopy confirmed throat swelling that threatened her airway. According to the medical team, she responded to a three-day course of intravenous dexamethasone, an immune-suppressing drug, alongside the antihistamine diphenhydramine.
Role of Anti-C1q Antibodies in Diagnostic Challenges
Laboratory evaluations revealed an atypical immune profile that pointed away from traditional C1-INH deficiency. The patient displayed normal C1-INH levels and function alongside low levels of complement proteins C4 and C1q, indicating abnormal complement consumption. Furthermore, blood tests showed elevated levels of antibodies against C1q and high C1q complement binding levels. The study authors proposed that these anti-C1q antibodies promote excessive complement activation, potentially influencing bradykinin production pathways despite the preservation of normal C1-INH function.
Over the subsequent six months, the patient suffered two additional hospitalizations for recurring swelling around her eyes and lips. Because her kidney function continued to decline—eventually necessitating dialysis—and her complement levels remained persistently low, physicians concluded her lupus activity remained uncontrolled. Her care team subsequently initiated Benlysta (belimumab), an approved SLE therapy, following which she reported no further angioedema episodes.
Frequently Asked Questions
What is systemic lupus erythematosus (SLE)?
Systemic lupus erythematosus is the most common form of lupus, an autoimmune disease where the body’s immune system mistakenly attacks healthy tissues and organs, frequently causing inflammation in the kidneys, skin, joints, and other systems.
How does complement-mediated angioedema differ from typical acquired angioedema?
Typical acquired angioedema involves a deficiency or dysfunction in the C1 esterase inhibitor protein. Complement-mediated angioedema in lupus occurs despite normal C1-INH levels and function, driven instead by abnormal activation of the complement immune protein network and anti-C1q antibodies.
Why is throat swelling dangerous in angioedema?
Swelling in the throat and upper airway can rapidly obstruct breathing, making it a medical emergency that requires prompt intervention to prevent life-threatening complications.
To stay informed on the latest developments in autoimmune disease research and clinical case studies, subscribe to our newsletter or explore our archives for more medical insights.
Related reading